Urological
Bladder, kidney, and prostate medications.
764 products in catalog
Pituitary/Pancreas/Kidney Drops
Liquid
Professional Complementary Health Formulas
Available to source
Prostate Drops
Liquid
Professional Complementary Health Formulas
Available to source
Prostate Drops
Liquid
Professional Complementary Health Formulas
Available to source
RET Bladder
Liquid
Professional Complementary Health Formulas
Available to source
ZORYVE (roflumilast)
1.5 mg/g · Cream
Arcutis Biotherapeutics, Inc.
Available to source
ZORYVE (roflumilast)
3 mg/g · Aerosol Foam
Arcutis Biotherapeutics, Inc.
Available to source
ZORYVE (roflumilast)
3 mg/g · Cream
Arcutis Biotherapeutics, Inc.
Available to source
Roflumilast
250 ug/1 · Tablet
Jubilant Cadista Pharmaceuticals Inc.
Available to source
Daliresp (roflumilast)
500 ug/1 · Tablet
AstraZeneca Pharmaceuticals LP
Available to source
Daliresp (roflumilast)
250 ug/1 · Tablet
AstraZeneca Pharmaceuticals LP
Available to source
Roflumilast
500 ug/1 · Tablet
Jubilant Cadista Pharmaceuticals Inc.
Available to source
ROFLUMILAST
500 ug/1 · Tablet
Solco Healthcare US, LLC.
Available to source
ZORYVE (roflumilast)
.5 mg/g · Cream
Arcutis Biotherapeutics, Inc.
Available to source
Roflumilast
250 ug/1 · Tablet
Novadoz Pharmaceuticals LLC
Available to source
Roflumilast
500 ug/1 · Tablet
Zydus Lifesciences Limited
Available to source
Roflumilast
500 ug/1 · Tablet
Camber Pharmaceuticals, Inc.
Available to source
Roflumilast
500 ug/1 · Tablet
Ascend Laboratories, LLC
Available to source
ROFLUMILAST
500 ug/1 · Tablet
Bryant Ranch Prepack
Available to source
Roflumilast
250 ug/1 · Tablet
Ascend Laboratories, LLC
Available to source
Roflumilast
500 ug/1 · Tablet
Zydus Pharmaceuticals USA Inc.
Available to source
Roflumilast
250 ug/1 · Tablet
MAJOR PHARMACEUTICALS
Available to source
Roflumilast
500 ug/1 · Tablet
Novadoz Pharmaceuticals LLC
Available to source
Roflumilast
500 ug/1 · Tablet
MAJOR PHARMACEUTICALS
Available to source
Roflumilast
500 ug/1 · Tablet
American Health Packaging
Available to source
